sirolimus eye drops(Fuzhou Haoji Medical Technology Development)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Namesirolimus eye drops(Fuzhou Haoji Medical Technology Development)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsXerophthalmiaEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFuzhou Haoji Medical Technology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuzhou Haoji Medical Technology Development Co Ltd
Active IndicationsN/A
Inactive IndicationsXerophthalmiaEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A